Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists

E Meller, M Goldstein and K Bohmaker

Millhauser Laboratories, Department of Psychiatry, New York University Medical Center, New York 10016.

The irreversible receptor antagonist N-ethoxycarbonyl-2-ethoxy-1,2- dihydroquinoline (EEDQ) was used to determine the relationship between receptor occupancy and response at central 5-hydroxytryptamine1A (5- HT1A) serotonin receptors mediating the inhibition of serotonin synthesis in rat cortex and hippocampus. Rats were treated with vehicle or EEDQ (2 or 6 mg/kg) and 24 hr later dose-response curves were constructed for inhibition of 5-hydroxytrytophan (5-HTP) accumulation (after decarboxylase inhibition with NSD-1015) by the selective 5-HT1A agonists 8-hydroxy-2(di-n-propylamino)tetralin (8-OH-DPAT) (0.01-3 mg/kg), buspirone (0.1-7.5 mg/kg), and ipsapirone (0.1-6.25 mg/kg) and the 5-HT1A agonist/antagonist BMY 7378 (0.015-5 mg/kg). In vehicle- pretreated rats, a similar maximal inhibition of 5-HT synthesis (range, 52-59%) was observed in both brain areas with 8-OH-DPAT, buspirone, and ipsapirone. These three agonists were also more potent in reducing 5- HTP accumulation in the cortex than in the hippocampus (ED50, 8-OH- DPAT, 14 and 30 microgram/kg; buspirone, 0.42 and 0.63 mg/kg; ipsapirone, 0.44 and 1.26 mg/kg, respectively). In the cortex, EEDQ treatment shifted the dose-response curves for 8-OH-DPAT, buspirone, and ipsapirone 8.6-, 2.0-, and 2.8-fold to the right, respectively. Corresponding rightward shifts in the hippocampus were smaller, 6.0-, 1.6-, and 2.1-fold, respectively. The EEDQ-induced shifts in the dose- response curves were accompanied by reductions in maximal response. In contrast, whereas the maximal inhibition of cortical 5-HTP accumulation by BMY 7378 (55%) was similar to that obtained with the agonists, maximal response in the hippocampus was much smaller (32%). Furthermore, in both brain regions EEDQ reduced the maximal response to BMY 7378 without shifting the dose-response curves. Analysis of the data by the double-reciprocal method of Furchgott, followed by calculation of fractional receptor occupancy for each dose of agonist, revealed a nonlinear relationship between receptor occupancy and response for 8-OH-DPAT, buspirone, and ipsapirone in both brain regions, demonstrating the presence of a large receptor reserve. For BMY 7378, in contrast, linear relationships were obtained. Because 5- HT1A receptor-mediated regulation of 5-HT synthesis appears to be mediated by somatodendritic autoreceptors on 5-HT neurons in the midbrain raphe nuclei, the results suggest that these autoreceptors possess a large receptor reserve for agonists. The relevance of these findings for the mechanism of action of nonbenzodiazepine anxiolytics is discussed.

Volume 37, Issue 2, pp. 231-237, 02/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				D. Mamo, A. Graff, R. Mizrahi, C. M. Shammi, F. Romeyer, and S. Kapur Differential Effects of Aripiprazole on D2, 5-HT2, and 5-HT1A Receptor Occupancy in Patients With Schizophrenia: A Triple Tracer PET Study Am J Psychiatry, September 1, 2007; 164(9): 1411 - 1417. [Abstract] [Full Text] [PDF]

				P. J. Pauwels and F. C. Colpaert Ca2+ Responses in Chinese Hamster Ovary-K1 Cells Demonstrate an Atypical Pattern of Ligand-Induced 5-HT1A Receptor Activation J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 608 - 614. [Abstract] [Full Text] [PDF]

				F. Yasuno, T. Suhara, T. Nakayama, T. Ichimiya, Y. Okubo, A. Takano, T. Ando, M. Inoue, J. Maeda, and K. Suzuki Inhibitory Effect of Hippocampal 5-HT1A Receptors on Human Explicit Memory Am J Psychiatry, February 1, 2003; 160(2): 334 - 340. [Abstract] [Full Text] [PDF]

				N. Froger, A. M. Gardier, R. Moratalla, I. Alberti, I. Lena, C. Boni, C. De Felipe, N. M. J. Rupniak, S. P. Hunt, C. Jacquot, et al. 5-Hydroxytryptamine (5-HT)1A Autoreceptor Adaptive Changes in Substance P (Neurokinin 1) Receptor Knock-Out Mice Mimic Antidepressant-Induced Desensitization J. Neurosci., October 15, 2001; 21(20): 8188 - 8197. [Abstract] [Full Text] [PDF]

				E. Meller, H. Li, K. D. Carr, and J. M. Hiller 5-Hydroxytryptamine1A Receptor-Stimulated [35S]GTPgamma S Binding in Rat Brain: Absence of Regional Differences in Coupling Efficiency J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 684 - 691. [Abstract] [Full Text]

				C. A. Fornal, F. J. Martin, C. W. Metzler, and B. L. Jacobs Pindolol Suppresses Serotonergic Neuronal Activity and Does Not Block the Inhibition of Serotonergic Neurons Produced by 8-Hydroxy-2-(di-n-propylamino)tetralin in Awake Cats J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 229 - 238. [Abstract] [Full Text]

				T. A. Cleland and C. Linster Concentration Tuning Mediated by Spare Receptor Capacity in Olfactory Sensory Neurons: A Theoretical Study Neural Comput., October 1, 1999; 11(7): 1673 - 1690. [Abstract] [Full Text]

				G. Pineyro and P. Blier Autoregulation of Serotonin Neurons: Role in Antidepressant Drug Action Pharmacol. Rev., September 1, 1999; 51(3): 533 - 591. [Abstract] [Full Text] [PDF]

				K. Tada, K. Kasamo, N. Ueda, T. Suzuki, T. Kojima, and K. Ishikawa Anxiolytic 5-Hydroxytryptamine1A Agonists Suppress Firing Activity of Dorsal Hippocampus CA1 Pyramidal Neurons through a Postsynaptic Mechanism: Single-Unit Study in Unanesthetized, Unrestrained Rats J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 843 - 848. [Abstract] [Full Text]

				P. J. Winsauer, F. H. Rodriguez, A. E. Cha, and J. M. Moerschbaecher Full and Partial 5-HT1A Receptor Agonists Disrupt Learning and Performance in Rats J. Pharmacol. Exp. Ther., January 1, 1999; 288(1): 335 - 347. [Abstract] [Full Text]

				J. Dong, C. d. Montigny, and P. Blier Full Agonistic Properties of Bay x 3702 on Presynaptic and Postsynaptic 5-HT1A Receptors Electrophysiological Studies in the Rat Hippocampus and Dorsal Raphe. J. Pharmacol. Exp. Ther., September 1, 1998; 286(3): 1239 - 1247. [Abstract] [Full Text]

				M. J. Millan, A. Gobert, A. Newman-Tancredi, V. Audinot, F. Lejeune, J.-M. Rivet, D. Cussac, J.-P. Nicolas, O. Muller, and G. Lavielle S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: I. Receptorial and Neurochemical Profile in Comparison with Clozapine and Haloperidol J. Pharmacol. Exp. Ther., September 1, 1998; 286(3): 1341 - 1355. [Abstract] [Full Text]

				J. Pineda, J. A. Ruiz-Ortega, and L. Ugedo Receptor Reserve and Turnover of Alpha-2 Adrenoceptors that Mediate the Clonidine-Induced Inhibition of Rat Locus Coeruleus Neurons In Vivo J. Pharmacol. Exp. Ther., May 1, 1997; 281(2): 690 - 698. [Abstract] [Full Text]

				Y. G. Ni, N. Camacho, and R. Miledi Irreversible antagonism of 5HT2c receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) PNAS, March 18, 1997; 94(6): 2715 - 2718. [Abstract] [Full Text] [PDF]

				F. Lejeune, A. Newman-Tancredi, V. Audinot, and M. J. Millan Interactions of (+)- and (-)-8- and 7-Hydroxy-2-(Di-n-Propylamino)tetralin at Human (h)D3, hD2 and h Serotonin1A Receptors and Their Modulation of the Activity of Serotoninergic and Dopaminergic Neurones in Rats J. Pharmacol. Exp. Ther., March 1, 1997; 280(3): 1241 - 1249. [Abstract] [Full Text]

				K. Njung'e, M. A. E. Critchley, and S. L. Handley Effects of beta-adrenoceptor ligands in the elevated X-maze 'anxiety' model and antagonism of the 'anxiogenic' response to 8-OH-DPAT J Psychopharmacol, January 1, 1993; 7(2): 173 - 180. [Abstract] [PDF]